Hürthle cell carcinoma: Time for a drastic change?

Cancer

Volumn 96, Issue 5, 2002, Pages 259-260

  Skoog, Lambert ^a   Tani, Edneia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ASPIRATION BIOPSY; BENIGN TUMOR; CARCINOMA; CELL PROLIFERATION; CYTOLOGY; DIAGNOSTIC ACCURACY; MALIGNANT NEOPLASTIC DISEASE; METAPLASIA; ONCOCYTOMA; PRIORITY JOURNAL; SHORT SURVEY; SUBTOTAL THYROIDECTOMY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; TUMOR CELL;

ADENOMA, OXYPHILIC; BIOPSY, NEEDLE; DIAGNOSTIC ERRORS; HUMANS; KI-67 ANTIGEN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UNNECESSARY PROCEDURES;

EID: 0037174791     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10796     Document Type: Short Survey

References (5)

1. Renshaw AR. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: Defining more consistent and specific cytologic criteria. Cancer (Cancer Cytopathol). 2002;96:261-266.
2. Rosai J, Carcangiu ML, De Lellis RA. Tumors of the Thyroid Gland. Washington DC: Armed Forces Institute of Pathology, 1990.
3. Erickson LA, Jin L, Goellner JR, et al. Pathologic features, proliferative activity and cyclin D1 expression in Hürthle cell neoplasms of the thyroid. Mod Pathol. 2000;13:186-192.
4. Cor A. Proliferative activity of Hürthle cell thyroid tumors. Oncology. 1999;57:17-22.
5. Hamperl H. Benign and malignant oncocytoma. Cancer. 1962;15:1019-1027.